ASTOR HOLDINGS II INC
10-Q, 1996-11-18
MISCELLANEOUS CHEMICAL PRODUCTS
Previous: FIRST GOLDEN AMERICAN LIFE INSURANCE CO OF NEW YORK, S-1, 1996-11-18
Next: NEWSOUTH BANCORP INC, S-1, 1996-11-18



<PAGE>

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

                          SECURITIES AND EXCHANGE COMMISSION
                               WASHINGTON, D.C.  20549

                                      FORM 10-Q

(Mark One)

/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the Quarterly Period Ended September 30, 1996

OR

/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

    For the Transition Period from_________________to_________________


Commission file number 333-14913-01
                      

                             ASTOR HOLDINGS II, INC.
                (Exact Name of Registrant as Specified in its Charter)


 DELAWARE                                            25-1766332
 (State or other jurisdiction of                     (I.R.S. Employer
 incorporation or organization)                      identification number)

 8521 SIX FORKS ROAD, RALEIGH, NORTH CAROLINA        27615
                                                     (Zip code)
 (Address of principal executive offices)

                                    (919) 846-8011

                 (Registrant's telephone number, including area code)

    Indicate by check mark whether the registrant:  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                                            Yes      No  X

              APPLICABLE ONLY TO CORPORATE ISSUERS:

    Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.

    Shares of Common Stock outstanding as of November 14, 1996: 1,000.

- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------

<PAGE>

                         PART I.  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS.


<TABLE>
<CAPTION>

                                                           Astor Holdings II, Inc.
                                            Unaudited Consolidated Condensed Statements of Income
                                                               (in thousands)


                                                                      Second Quarter Ended                   Six Months Ended
                                                                         September 30,                         September 30,
                                                                  ---------------------------           ---------------------------
                                                                    1996               1995               1996             1995(1)
                                                                    ----               ----               ----             -------
 <S>                                                              <C>                <C>                <C>                <C>
 Sales                                                            $ 44,604           $ 37,365           $ 87,827           $ 54,195
 Cost of sales                                                      34,418             29,605             67,736             44,189
                                                                  --------           --------           --------           --------
 Gross profit before depreciation                                   10,186              7,760             20,091             10,006
 Selling, general and administrative
   expenses                                                          4,577              3,705              9,010              5,024
                                                                  --------           --------           --------           --------
 Operating profit before interest,
   depreciation, amortization, taxes,
   extraordinary items                                               5,609              4,055             11,081              4,982
 Income (loss) from investment in
   Rheochem                                                            225                (65)               441                (65)
                                                                  --------           --------           --------           --------
 EBITDA                                                              5,834              3,990             11,522              4,917
 Depreciation and amortization                                       1,792              1,690              3,345              2,243
 Interest expense                                                    1,607              1,464              3,276              1,837
 Reorganization expense                                                                                                         856
                                                                  --------           --------           --------           --------
 Income (loss) before taxes and
   extraordinary items                                               2,435                836              4,901                (19)
 Provision for income taxes                                         (1,242)               566               (190)               566
                                                                  --------           --------           --------           --------
 Income (loss) before extraordinary items
                                                                     3,677                270              5,091               (585)
 Extraordinary item - gain on cancellation
   of debt                                                                                                                   44,933
                                                                  --------           --------           --------           --------
 Net income                                                       $  3,677           $    270           $  5,091           $ 44,348
                                                                  --------           --------           --------           --------


</TABLE>
 
(1) Astor Holdings II's consolidated income for the six month period ended
    September 30, 1995 includes the results of operations of Associated British
    Industries Limited ("ABI") for the approximately three months following the 
    ABI acquisition on June 28, 1995.


The accompanying notes are an integral part of these consolidated condensed
financial statements.

<PAGE>
                               Astor Holdings II, Inc.
                        Consolidated Condensed Balance Sheets
                                    (in thousands)

                                               (Unaudited)
                                               September 30,   March 31,
                                                  1996           1996
                                               -------------------------
Assets
Current assets:
 Cash and cash equivalents                      $ 1,765           $ 1,157
 Accounts receivable (net of allowance
  for doubtful accounts of $725 and $726,
  respectively)                                  23,645            23,811
 Receivable from Rheochem Technologies, Inc.        635               566
 Inventory                                       21,836            18,586
 Prepaid expenses                                 1,862             1,755
 Other current assets                             2,362             1,604
                                               --------------------------
Total current assets                             52,105            47,479

Property, plant and equipment:
 Land and improvements                            7,633             7,442
 Buildings and improvements                       7,098             7,078
 Machinery and equipment                         42,292            40,896
                                               --------------------------
Total cost                                       57,023            55,416
 Less accumulated depreciation                   (6,059)           (4,461)
                                               --------------------------
Property, plant and equipment - net              50,964            50,955

Investment in Rheochem Technologies, Inc.         4,392             4,040

Goodwill                                         29,181            29,940

Other intangible assets                           6,161             6,572

Deferred tax asset                                4,692             3,920
                                               --------------------------
Total assets                                   $147,495          $142,906
                                               --------------------------

Liabilities and Shareholder's Equity
Current liabilities:
 Accounts payable                              $ 16,309          $ 16,271
 Accrued interest payable                           522               816
 Accrued expenses                                 8,087             5,770
 Current portion of long-term debt                5,361             4,747
                                               --------------------------
Total current liabilities                        30,279            27,604

Long-term debt                                   62,846            66,070

Due to affiliated company                         5,263             5,436

Deferred income taxes                             4,856             4,782

Other long-term liabilities                       2,472             2,657

Shareholder's Equity:
 Common stock:
 Par value $.01 per share; authorized 10,000
  shares issued and outstanding, 1,000 shares
 Additional paid-in capital                      36,671            36,671
 Reinvested earnings - net of transfer of 
  $23,864 accumulated deficit as a result of
  the March 31, 1996 quasi-reorganization         5,091              --
 Foreign currency translation adjustment             17              (314)
                                               --------------------------
Total stockholder's equity                       41,779            36,357
                                               --------------------------
Total liabilities and stockholder's equity     $147,495          $142,906
                                               --------------------------


The accompanying notes are an integral part of these consolidated condensed
financial statements.

<PAGE>
                              Astor Holdings II, INC.
              Unaudited Consolidated Condensed Statements of Cash Flows
                                  (in thousands)


<TABLE>
<CAPTION>

                                                 Six months ended September 30,
                                                       1996           1995
                                                 ------------------------------
<S>                                                   <C>           <C>
OPERATING ACTIVITIES
Net income. . . . . . . . . . . . . . . . . . . . .   $5,091         $44,348
Adjustments to reconcile net income to net
 cash provided by operating activities:
   Depreciation and amortization. . . . . . . . . .    3,345           2,243
   Income from debt cancellation. . . . . . . . . .        -         (44,933)
   Equity income in Rheochem Technologies, Inc. . .     (441)             65
   Changes in operating assets and liabilities
    (net of business acquired on June 28, 1995) 
   Cash escrow. . . . . . . . . . . . . . . . . . .        -             102
   Accounts receivable. . . . . . . . . . . . . . .      243          (2,793)
   Receivable from Rheochem Technologies, Inc.. . .      (69)            (39)
   Inventory. . . . . . . . . . . . . . . . . . . .   (3,177)         (2,597)
   Prepaid and other current assets . . . . . . . .     (866)          1,484
   Deposits . . . . . . . . . . . . . . . . . . . .        -              51
   Restricted Cash. . . . . . . . . . . . . . . . .        -             175
   Accounts payable . . . . . . . . . . . . . . . .       49            (114)
   Accrued reorganization costs . . . . . . . . . .        -            (466)
   Deferred taxes - net . . . . . . . . . . . . . .     (698)            128
   Other long-term liabilities. . . . . . . . . . .     (185)            561
   Accrued interest payable . . . . . . . . . . . .     (294)            178
   Accrued expenses . . . . . . . . . . . . . . . .    2,317           6,516
                                                      ------          ------ 
Net cash provided by operating activities              5,315           4,909

INVESTING ACTIVITIES
Additions to property, plant and equipment. . . . .   (2,094)         (1,786)
Acquisition of business . . . . . . . . . . . . . .        -         (66,777)
                                                      ------          ------
Net cash used in investing activities . . . . . . .   (2,094)         68,563

FINANCING ACTIVITIES
Capital lease payments. . . . . . . . . . . . . . .        -             (18)
Proceeds from long-term debt, net of fees . . . . .        -          60,986
Payment of long-term debt . . . . . . . . . . . . .   (2,610)         (4,256)
Issuance of stock, net of fees. . . . . . . . . . .        -          30,377
Payment of PCDR inventory financing . . . . . . . .        -          (3,600)
Payment of debtor in possession financing . . . . .        -          (3,500)
Payment of bridge loan payable. . . . . . . . . . .        -          (5,000)
Payment of pre-petition liabilities . . . . . . . .        -          (8,827)
Decrease in due to affiliated company . . . . . . .     (172)           (316)
                                                      ------          ------
Net cash (used in) provided by financing
 activities . . . . . . . . . . . . . . . . . . . .   (2,782)         65,846
                                                      ------          ------

Effect of Exchange Rate Changes on Cash . . . . . .      169            (502)

Net increase in cash and cash equivalents . . . . .      608           1,690
Cash and cash equivalents at beginning of period. .    1,157             719
                                                      ------          ------
Cash and cash equivalents at end of period. . . . .   $1,765          $2,409
                                                      ------          ------

</TABLE>

The accompanying notes are an integral part of these consolidated condensed
financial statements.

<PAGE>
                                 Astor Holdings II, Inc.
             Notes to Unaudited Consolidated Condensed Financial Statements

Note 1 - Basis of Presentation

    The accompanying financial statements of Astor Holdings II, Inc. 
(together with its subsidiaries, "Astor Holdings II" or the "Company") are 
unaudited and have been prepared in accordance with generally accepted 
accounting principles for interim financial information and with Article 10 
of Regulation S-X.  Accordingly, they do not include all of the information 
and footnotes required by generally accepted accounting principles for 
complete financial statements.  The unaudited financial statements should be 
read in conjunction with the audited financial statements and footnotes for 
the year ended March 31, 1996.  In the opinion of management, all adjustments 
and normal recurring accruals considered necessary for a fair presentation of 
the results for the interim period have been included.  The interim results 
reflected in the unaudited financial statements are not necessarily 
indicative of expected results for the full year.

    EBITDA represents earnings before interest expense, income tax expense, 
depreciation and amortization expense, extraordinary items and non-recurring 
items. Information concerning EBITDA is included as it is used by certain 
investors as a measure of a company's ability to service its debt. EBITDA 
should not be used as an alternative to, or be construed as more meaningful 
than, operating income or cash flows or as an indicator of the operating 
performance or liquidity of Astor Holdings II.

<PAGE>

Note 2 - Inventory

                                                 September 30       March 31
Inventory consists of the following:                 1996             1996
                                                     ----             ----

Raw Materials                                            8,671          7,428
Work-in-progress                                         5,201          4,762
Finished goods                                           8,304          6,767
Allowance for inventory obsolescence                      (340)          (371)
                                                 ----------------------------
                                                        21,836         18,586
                                                 ----------------------------
                                                 ----------------------------


Note 3 -- Income Taxes

     Income tax expense recorded for the six month period ended September 
30, 1995 is greater than the amount computed by applying the U.S. federal 
income tax rate to income before taxes and extraordinary item as a result of 
taxes being provided on the income of a subsidiary of the Company which was 
not part of the consolidated federal tax return for the quarter ended 
September 30, 1995. Income tax expense recorded for the six month period 
ended September 30, 1996 is less than the amount computed by applying the 
U.S. federal income tax rate to income before taxes and extraordinary item 
due primarily to the elimination of a valuation allowance related to the 
Company's deferred  tax assets.


<PAGE>

Note 4 - Commitments and Contigencies

    As is prevalent in the refining industry, Astor Holdings II's operating 
subsidiary, Astor Corporation, has environmental issues that it is 
addressing.  The United States Refining Division has issues related to the 
remediation of contaminated soils and ground water. Quaker State Corporation 
(QSC) is responsible for the vast majority of the costs associated with the 
issues.  Astor Corporation's potential liability is limited to sharing fifty 
percent of the first $5,500,000 of non-ground water remediation with QSC.  
Astor Corporation will pay for its share of the above costs by issuing 
subordinated 9% notes payable to QSC, which will be due December 31, 2008.  
As of September 30, 1996, Astor Corporation has issued environmental notes to 
Quaker State in the amount of $160,079 for shared costs.  The future cost to 
Astor Corporation for non-ground water remediation, if any, is not known at 
this time.

    The United States Blending Division has environmental issues related to 
contamination at its Titusville, Pa. facility.  Under the terms of the 
L1,450,988 of 8% subordinated debt issued to ABI's former shareholders by 
Astor Holdings II's parent corporation, Astor Holdings, Inc. (the "Parent"), 
the Parent is entitled to set-off costs in excess of $350,000 relating to 
this site against the principal and interest otherwise payable, so long as 
the Parent notifies the shareholders by June 28, 1999 of the existence of a 
condition that could give rise to a set-off claim.  Astor Holdings II 
believes it has provided for probable losses with respect to these issues and 
does not anticipate a material impact on future operating results.

<PAGE>

Note 5 - Subsequent Event

    On October 8, 1996 the Company completed the acquisition of Adco 
Technologies, Inc. ("ADCO"), a Michigan based manufacturer and marketer of 
specialty adhesives and sealants for $54.4 million.  The acquisition was 
financed through the private placement of $110 million of 10.5% Senior 
Subordinated Notes maturing October 15, 2006 (the "Notes").  The remaining 
net proceeds from the Notes were used to repay outstanding indebtedness under 
the Union Bank of Switzerland ("UBS") Credit Facility and expenses.  The 
Company also entered into a Senior Credit Agreement with The Chase Manhattan 
Bank providing for a six-year term loan denominated in sterling in an amount 
equivalent to $20.0 million and a six-year revolving credit facility of $30.0 
million. 

    On October 25, 1996 the Company filed with the Securities and Exchange 
Commission a registration statement relating to $110 million of 10.5% Series 
B Senior Subordinated Notes Due 2006 of Astor Corporation which are to be 
exchanged for the like amount of privately placed 10.5% Senior Subordinated 
Notes Due 2006 of Astor Corporation issued on October 8, 1996.


<PAGE>

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS.


RESULTS OF OPERATIONS
- ---------------------

COMPARISON OF THE SIX MONTHS ENDED SEPTEMBER 30, 1996 WITH THE SIX MONTHS ENDED
SEPTEMBER 30, 1995


    SALES.  Sales of Astor Holdings II, Inc. (together with its subsidiaries,
"Astor Holdings II" or the "Company") increased by $33.6 million from $54.2 
million for the six months ended September 30, 1995 to $87.8 million for the 
six months ended September 1996.  Of this sales increase, $26.1 million is 
related to the acquisition of ABI on June 28, 1995.  Excluding the impact of 
ABI, sales increased $7.5 million or 23% as a result of: (i) higher volume 
sales due to the capacity improvements achieved from the capital spending 
program completed in January 1996; (ii) higher specialty wax prices realized 
in the U.S.; (iii) a more focused marketing effort provided by the addition 
of ABI's sales force; and (iv) a shift in sales from lower priced applications
to higher value applications.

    GROSS PROFIT.  Gross profit increased by $10.1 million from $10.0 million 
for the six months ended September 1995 to $20.1 million for the six months 
ended September 30, 1996, with $8.0 million of the increase attributable to 
the acquisition of ABI.  Gross profit as a percentage of sales increased from 
18.5% for the six months ended September 30, 1995 to 22.9% for the six months 
ended September 30, 1996 as a result of the acquisition and improved margins 
in the Company's business.  Excluding the effect of the acquisition of ABI, 
gross profit as a percentage of sales improved from 13.1% for the six months 
ended September 30, 1995 to 16.0% for the six months ended September 30, 1996 
principally as a result of the reasons discussed above.

    SELLING, GENERAL AND ADMINISTATIVE EXPENSES.  Selling, general and
administrative expenses increased by $4.0 million from $5.0 million for the six
months ended September 1995 to $9.0 million for the six months ended September
1996.  Selling, general and administrative expenses as a percentage of sales
increased from 9.3% to 10.3%.  The increase was primarily associated with the
expansion of the business as a result of the acquisition of ABI.  The $4.0
million increase is comprised of (i) $1.3 million of additional selling related
costs associated with ABI product sales, (ii) $1.8 million of administrative
costs associated with the acquired ABI businesses and (iii) $0.9 million
associated with planned staff increases to support the new larger company and
the Company's growth strategy.

    INCOME FROM RHEOCHEM.  The Company's share of equity earnings form 
Rheochem was $0.4 million for the six months period ended September 1996 
compared to a $0.1 million loss from Rheochem for the six months ended 
September 30, 1995.  The Company acquired its interest in Rheochem on 
June 28, 1995 with the acquistion of ABI.

    DEPRECIATION AND AMORTIZATION.  Depreciation and amortization expense
increased by $1.1 million from $2.2 million for the six months ended September
30, 1995 to $3.3 million for the six months ended September 30, 1996 primarily
due to the acquisition of ABI.

    INTEREST EXPENSE, NET.  Interest expense, net, increased by $1.5 million
from $1.8 million for the six months ended September 30, 1995 to $3.3 million
for the six months ended September 30, 1996.  This increase was primarily due to
the increased debt incurred in connection with the acquisition of ABI.

    NONRECURRING EXPENSES.  The $0.9 million of reorganization expenses for 
the six months ended September 1995 were attributable to professional fees 
associated with the emergence from bankruptcy of the Company's operating 
subsidiary, Astor Corporation.  No costs related to the acquisition of ABI or 
Astor Corporation's emergence from bankruptcy occurred in the 1996 period or 
are expected in the future.

    EXTRAORDINARY ITEM - GAIN ON CANCELLATION OF DEBT.  An extraordinary item
resulting from the gain on cancellation of debt of $44.9 million was recorded in
the six months ended September 1995 reflecting the discharge of pre-bankruptcy
petition indebtedness of Astor Corporation.


                                          3 
<PAGE>

    NET INCOME BEFORE EXTRAORDINARY ITEMS.  As a result of the factors 
discussed above, the acquisition of ABI and improved performance of the 
Company's business, net income before extraordinary items for the six months 
ended Spetember 30, 1996 was $5.1 million while the six months period ended 
September 30, 1995 showed a $0.6 million net loss before extraordinary items.

LIQUIDITY AND CAPITAL RESOURCES

     Net cash provided by operating activities for the six months ended 
September 30, 1996 was $5.3 million compared to $4.9 million for the six 
months ended September 30, 1995. The $5.3 million of net cash provided in the 
six months ended September 30, 1996 was primarily due to cash flow from 
operating profits of $7.3 million offsetting a $2.0 million use of cash from 
working capital, resulting from an increase in inventories due to higher 
sales. The $4.9 million source of cash provided for the six months ended 
September 30, 1995 was primarily due to $1.7 million of cash flow from 
operating profits and a $3.2 million source of cash from working capital, 
resulting from an increase in accrued expenses which offset increased 
inventories and accounts receivable due to higher sales.

     Cash used in investing activities for the six months ended September 30, 
1996 and 1995 was $2.1 million and $68.6 million, respectively. The use of 
cash for the six months ended September 1996 was primarily due to capital 
expenditures. The use of cash for the six months ended September 30, 1995 was 
due to the ABI acquisition costs of $66.8 million and capital expenditures of 
$1.8 million. The Company expects that capital expenditure requirements will 
be approximately $3.4 million for fiscal year 1997 and approximately $0.6 
million for the ADCO operations following the ADCO acquisition, resulting in 
total capital expenditures of $4.0 million for fiscal 1997. Astor expects to 
fund future capital expenditures primarily from cash generated from operating 
activities, except that Astor purchased ADCO with proceeds from the Notes 
Offering and the Senior Bank Facility (as described below).

     Cash used for financing activities for the six months ended September 
1996 was $2.8 million due to debt repayments of an outstanding term loan of 
$2.0 million and a $0.6 million reduction in the Company's revolving Loan 
borrowings. Cash provided by financing activities of $65.8 million for the 
six months ended September 30, 1995 was due to (i) proceeds from the 
long-term debt issuance of $60.9 million, net of fees, (ii) $30.4 million 
from the issuance of stock and warrants, net of fees, and (iii) the repayment 
of $25.4 million of existing debt and settlement of bankruptcy claims.

     On October 8, 1996 the Company completed the acquisition of Adco 
Technologies, Inc. ("ADCO"), a Michigan based manufacturer and marketer of 
specialty adhesives and sealants for $54.4 million. The acquisition was 
financed through the private placement of $110 million of 10.5% Senior 
Subordinated Notes maturing October 15, 2006 (the "Notes"). The remaining net 
proceeds from the Notes were used to repay outstanding indebtedness under the 
Union Bank of Switzerland ("UBS") Credit Facility and expenses. The Company 
also entered into a Senior Credit Agreement with The Chase Manhattan Bank 
providing for a six-year term loan denominated in sterling in an amount 
equivalent to $20.0 million and a six-year revolving credit facility of $30.0 
million. 

     The Company's primary capital requirements consist of debt service and 
capital expenditures. The required debt amortization payments under the New 
Senior Bank Facility for the next five fiscal years are: (i) no amortization 
payments in fiscal year 1997, (ii) $1.4 million in fiscal year 1998, (iii) 
$1.8 million in fiscal year 1999, (iv) $3.0 million in fiscal year 2000 and 
(v) $4.5 million in fiscal year 2001. The Bank Term Loan and Revolving Credit 
Facility borrowings under the Senior Bank Facility bear interest at the 
election of the Company at an interest rate determined either by Chase 
Manhattan Bank's prime lending rate plus an initial margin of 1.25% or the 
eurodollar rate specified in the Senior Bank Facility plus an initial margin 
of 2.5%. The Senior Bank Facility and the Notes impose various restrictions 
and covenants on the Company, including, among other things, financial 
covenants relating to the maintenance of minimum fixed charge coverage ratios 
and interest coverage ratios as well as restrictions on indebtedness, 
guarantees, acquisitions, capital expenditures, investments, loans, liens, 
dividends and other 

<PAGE>
restricted payments and asset sales. The Company estimates that approximately 
$3.5 million is required annually for maintenance and improvements of its 
facilities. The Company's principal source of cash to fund these capital 
requirements is cash generated from operating activities.

     SEASONALITY. Based on the historical performances of Astor Corporation
and ADCO, management expects the Company's future performance to display 
seasonal fluctuations, with the first fiscal quarter being the strongest 
quarter and the third fiscal quarter being the weakest.

     FOREIGN EXCHANGE EXPOSURE. The functional currency for the majority of 
the Company's foreign operations is the applicable local currency. The bulk 
of the Company's foreign sales, raw materials, expenses, assets, and liabilities
(including bank debt) are denominated in the local currency, providing for a 
natural hedge for currency exposure. For a small portion of foreign sales 
transactions, the Company uses forward foreign exchange contracts to mitigate 
exposure. The translation from the applicable foreign currency to U.S. 
dollars is performed for balance sheet accounts using current exchange rates 
in effect at the balance sheet date and for revenue and expense accounts 
using a weighted average exchange rate during the period. Translation 
adjustments resulting from such translation were $0.3 million at March 31, 
1996.

FORWARD LOOKING STATEMENTS.  

     The foregoing "Management's Discussion and Analysis of Financial 
Condition and Results of Operations" contains "forward looking statements" 
within the meaning of Section 27A of the Securities Act of 1933, as amended, 
and Section 21E of the Securities Exchange Act of 1934, as amended, which 
represent the Company's expectations or beliefs concerning future events, 
including, but not limited to, the following: statements regarding future 
capital expenditures and the source of funding for future capital 
expenditures; statements regarding the Company's primary capital 
requirements; statements regarding the Company's required debt amortization 
payments under the Senior Bank Facility; statements regarding the amounts 
required annually for maintenance and improvements of the Company's 
facilities and the source of cash to fund such capital requirements; and 
statements regarding seasonal fluctuations in the Company's future 
performance.  The Company cautions that these statements are further 
qualified by important factors that could cause actual results to differ 
materially from those in the forward looking statements, including without 
limitation, the following: growth in the business, as a result of 
acquisitions or internal growth, affecting future capital expenditures; 
technological change in equipment used in developing and manufacturing the 
Company's products; damage, destruction or other casualty loss with respect 
to the Company's fixed plant or equipment; insufficient cash flow from 
operations to fund anticipated capital expenditures and scheduled debt 
payments; changes in the Company's debt and capital structure, including 
amendments to the Senior Bank Facility; and shifts in product mix changing 
the effect of seasonality on the Company's future performance.  Results actually
achieved thus may differ materially from expected results included in these and 
other forward looking statements.

                                      4

<PAGE>

                             PART II.  OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

    The Company has been named as a defendant, along with 92 other companies, 
in a class action lawsuit in Texas.  The suit alleges personal injury, death 
and other damages arising out of the plaintiffs' exposure to a variety of 
building materials and other products while working at the Corpus Christi 
Army Depot.  The plaintiffs, who are seeking approximately $500 million in 
damages, appear to have named as defendants the manufacturers of every 
substance known to have been used over an extended period at the Army Depot.  
The Company product involved appears to be a sealant used in the installation 
and repair of commercial roofing.  The Company's insurance carrier is 
currently defending this action on behalf of the Company.  While the case is 
still in the early stages of discovery, according to the insurer, no evidence 
has been produced to date linking the Company sealants to any of the 
plaintiffs' claims.

ITEM 2.  CHANGES IN SECURITIES.

         None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

         None.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

         None.

ITEM 5.  OTHER INFORMATION.

         None.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K:

         (a)  Exhibits.

              27.  Financial Data Schedule.

         (b)  Reports on Form 8-K.

              There were no reports filed on Form 8-K during the three months 
              ended September 30, 1996.
<PAGE>


                                      SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Quarterly Report on Form 10-Q to be signed on
its behalf by the undersigned thereunto duly authorized.



 Dated:  November 14, 1996                   ASTOR HOLDINGS II, INC.

                                             By:  /s/ Boyd D. Wainscott
                                                ------------------------------
                                                  Boyd D. Wainscott
                                                  Chief Executive Officer


 Dated:  November 14, 1996                   By:  /s/ John F. Gottshall
                                                ------------------------------
                                                  John F. Gottshall
                                                  Chief Financial Officer




<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-1997
<PERIOD-START>                             APR-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                            1765
<SECURITIES>                                         0
<RECEIVABLES>                                    24370
<ALLOWANCES>                                       725
<INVENTORY>                                      21836
<CURRENT-ASSETS>                                  4859
<PP&E>                                           57023
<DEPRECIATION>                                    6059
<TOTAL-ASSETS>                                  147495
<CURRENT-LIABILITIES>                            30279
<BONDS>                                          60846
                                0
                                          0
<COMMON>                                             0
<OTHER-SE>                                       41779
<TOTAL-LIABILITY-AND-EQUITY>                    147495
<SALES>                                          87827
<TOTAL-REVENUES>                                 87827
<CGS>                                            67736
<TOTAL-COSTS>                                    78912
<OTHER-EXPENSES>                                   738
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                3276
<INCOME-PRETAX>                                   4901
<INCOME-TAX>                                     (190)
<INCOME-CONTINUING>                               5091
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      5091
<EPS-PRIMARY>                                     5091
<EPS-DILUTED>                                     5091
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission